Corporate

18
Sep

PRESS RELEASE – Genemarkers and Genoskin announce new partnership

Genemarkers and Genoskin are pleased to announce they have formed a partnership to provide exceptional value and service to researchers in the fields of cosmetic and pharmaceutical topical solutions. The Companies are currently performing collaborative work to understand how cannabidiol (CBD) acts in the skin.

26
Sep

Genoskin signs distribution agreement with Japanese distributor

Genoskin signs distribution agreement with Japan's Fujifilm Wako Pure Chemical The Genoskin team is excited to announce that we've signed an agreement with the Japanese Fujifilm Wako Pure Chemical Corporation to distribute Genoskin's ex vivo human skin models to customers in Japan. This agreement will enable Genoskin to respond to the specific needs of exisiting and potential customers in Japan and to increase its
Read more
17
Mar

CEO Innovation Award

On March 9th, 2017,  Genoskin won the Award for Innovation at the CEO Company Challenge meeting in Colomiers, France. The award highlights local companies that have special merit in the area of export, innovation and job creation. Genoskin wins CEO Award for Innovation In the light of today’s challenging economic context, the CEO West-Toulouse Company Club aims to highlight the driving efforts of

Read more

9
Mar

US Patent for human skin models

Genoskin obtains US patent for skin models Genoskin is pleased to announce the approval of a US patent for our "system for the maintenance and survival of skin biopsies in transport and its applications". The patent describes our method to transform human skin biopsies in ready-to-use and functional ex vivo skin models. The human skin biopsies that are used in our models
Read more
28
Feb

PRESS RELEASE – ISO9001 certification

“Genoskin is the first biotechnology company in the area to obtain the ISO9001:2015 certification” says Mr Bonzom. “This confirms their position as a trustworthy preclinical research partner for customers developing new drugs and products that need to be tested on human skin.”

15
May

Genoskin joins 3R In Vitro Testing Platform IVTIP

Genoskin joins 3R In Vitro Testing Platform Genoskin is proud to join the In Vitro Testing Industrial Platform. The IVTIP Platform was founded in 1993 and currently comprises 46 companies from different sectors (assay developers, technology providers, chemical, pharmaceutical and cosmetics companies). All members have significant in vitro testing activities. Most of the IVTIP member companies are from Europe, but IVTIP also has members in

Read more